On May 12th, listed company Jingjia Group (002191) on the Shenzhen Stock Exchange's investor Q&A platform responded to questions from investors. The company stated that its new tobacco business is expected to achieve a revenue of 550 million yuan in 2022, with over 200% growth for the second consecutive year. The company will focus on expanding its electronic cigarette business in Southeast Asia, the Middle East, the Russian-speaking region, and Japan. Its two Indonesian subsidiaries are engaged in trading operations and the production of HNB herbal pods, with Jingjia's new tobacco business in Indonesia expected to enter the capacity ramp-up and yield improvement phase after completing equipment commissioning in the first half of this year.
Below is the full transcript of the Q&A session:
Investors: Can you provide information on any potential areas of growth for the company in the future?
Jinjia Co., Ltd. (002191) has announced that its new tobacco business achieved revenue of 550 million yuan in 2022, continuing its high-speed growth of over 200% for two consecutive years. The company is producing within its licensed scope and quantity and providing ODM/OEM services for new tobacco products such as e-cigarettes, as well as conducting R&D, production, and sales of vape oil, heating non-burning aromatic flavors, and related new materials. Its associated company, Jiaju Electronics, has established a subsidiary, Hong Kong Viyon International Co., Ltd., in Hong Kong, which is mainly responsible for the development of new tobacco overseas channels and brand promotion, with a focus on electronic cigarette business in Southeast Asia, the Middle East, the Russian language market, and Japan. Additionally, the company has established two subsidiaries in Indonesia, Yunque Xinhe Indonesia and Jinjia New Tobacco Indonesia, which are respectively engaged in trade operations and production of HNB herbal pods. After completing equipment debugging in the first half of this year, Jinjia New Tobacco Indonesia will enter the stage of capacity ramp-up and yield improvement. Thank you for your attention.
References:
Question and answer content.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
